A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae--a possible vaccine.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1534713)

Published in Clin Exp Immunol on January 01, 1990

Authors

J Marolia1, P Robinson, P R Mahadevan

Author Affiliations

1: Foundation for Medical Research, Bombay, India.

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99

Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis (1966) 22.28

A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods (1980) 4.76

Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med (1979) 3.61

Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase. J Lab Clin Med (1975) 2.65

Killing of Mycobacterium microti by immunologically activated macrophages. Nature (1981) 2.62

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61

Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J Gen Microbiol (1978) 2.58

MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE. J Bacteriol (1965) 2.47

Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation. Infect Immun (1986) 1.52

Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. Int J Lepr Other Mycobact Dis (1989) 1.45

Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol (1986) 1.27

Toxic effect of the peroxidase-hydrogen peroxide-halide antimicrobial system on Mycobacterium leprae. Infect Immun (1984) 1.24

Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A (1988) 1.15

Ultrastructural and chemical studies on wall-deficient forms, spheroplasts and membrane vesicles from Mycobacterium aurum. J Gen Microbiol (1981) 0.96

Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide. Int J Lepr Other Mycobact Dis (1984) 0.96

Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide. J Med Microbiol (1985) 0.96

Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals. Infect Immun (1989) 0.95

Cyclosporine affects the function of antigen-presenting cells. Immunology (1986) 0.91

Susceptibility of Mycobacterium intracellulare to hydrogen peroxide. Am Rev Respir Dis (1984) 0.89

Superoxide production in pulmonary alveolar macrophages and killing of BCG by the superoxide-generating system with or without catalase. Infect Immun (1979) 0.88

Hydrogen peroxide and superoxide production by peripheral blood monocytes in leprosy. Clin Exp Immunol (1985) 0.87

Cellular immunity in lepromatous and tuberculoid leprosy. Immunol Lett (1985) 0.86

The effect of cytochalasin B on the superoxide production by alveolar macrophages obtained from normal rabbit lungs. J Reticuloendothel Soc (1982) 0.86

Host-pathogen interaction--new in vitro drug test systems against Mycobacterium leprae--possibilities and limitations. Lepr Rev (1986) 0.81

A rapid method for viability and drug sensitivity of Mycobacterium leprae cultured in macrophages and using fluorescein diacetate. Indian J Lepr (1987) 0.79

A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients. J Clin Lab Immunol (1987) 0.78

Articles by these authors

Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90

A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry (1996) 7.80

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA (1998) 7.00

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet (2004) 6.27

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (1993) 5.47

Relationship of the major constituents of the Neurospora crassa cell wall to wild-type and colonial morphology. J Bacteriol (1965) 4.06

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65

The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care (1995) 3.29

Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci U S A (1978) 2.41

Outcomes of "inadequate" antidepressant treatment. J Gen Intern Med (1995) 2.19

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med (1991) 2.06

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet (1998) 2.06

Osteoarthritis of the thumb carpometacarpal joint: correlation of ultrasound appearances to disability and treatment response. Clin Radiol (2012) 2.00

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81

Ultrasound for initial evaluation and triage of clinically suspicious soft-tissue masses. Clin Radiol (2009) 1.80

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. Int J Clin Pract (2010) 1.78

Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta (1989) 1.73

Iliopsoas abscess--a review and update on the literature. Int J Surg (2012) 1.70

To retract or not to retract. Br Dent J (1990) 1.70

Nasal packing after routine nasal surgery--is it justified? J Laryngol Otol (1993) 1.66

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. Antimicrob Agents Chemother (1996) 1.65

Do affluent societies have the only options for the best therapy? Leukemia (2007) 1.63

Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect (1994) 1.62

Factors affecting the incidence of deep wound infection after hip fracture surgery. J Bone Joint Surg Br (2012) 1.61

Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol (1997) 1.57

Therapeutic impact of percutaneous spinal biopsy in spinal infection. Postgrad Med J (2004) 1.54

Saccharomyces cerevisiae synthesizes proteins related to the p21 gene product of ras genes found in mammals. Mol Cell Biol (1984) 1.53

Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. Int J Lepr Other Mycobact Dis (1989) 1.45

Cell-free human amniotic fluid as culture medium for mouse and human embryos. Fertil Steril (1989) 1.41

Inosine.adenine base pairs in a B-DNA duplex. Nucleic Acids Res (1987) 1.40

Occupational health practice in New Zealand. N Z Med J (1999) 1.39

Localization of structural polymers in the cell wall of Neurospora crassa. J Cell Biol (1967) 1.38

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther (1999) 1.37

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil (2009) 1.27

The predictors of persistence of depression in primary care. J Affect Disord (1994) 1.24

Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients. Infect Immun (1983) 1.24

Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res (1983) 1.24

Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group. Cancer (1990) 1.24

Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities. Aust N Z J Public Health (1997) 1.24

Conserved mRNA from the conidia of Neurospora crassa. Mol Gen Genet (1970) 1.23

Maternal cigarette smoking is associated with increased inner airway wall thickness in children who die from sudden infant death syndrome. Am J Respir Crit Care Med (1998) 1.21

A case of aspartate aminotransferase macroenzyme. Ann Clin Biochem (2008) 1.21

Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol (1995) 1.17

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharm Drug Dispos (1999) 1.16

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther (2010) 1.16

Effect of deoxyfructoserotonin (DFS) on lepromatous leprosy. Lancet (1988) 1.15

Transventricular aortic valvotomy for critical aortic stenosis in infants. J Thorac Cardiovasc Surg (1987) 1.10

Ascorbic Acid, Riboflavin, Thiamin, and Nicotinic Acid in Relation to Severe Injury, Hemorrhage, and Infection in the Human. Ann Surg (1946) 1.10

Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther (2011) 1.10

Manuscript evolution. Trends Genet (2001) 1.09

Diffusion and dissemination of evidence-based cancer control interventions. Evid Rep Technol Assess (Summ) (2003) 1.08

Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine. AIDS (2001) 1.07

Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J Neurosci Res (1989) 1.07

Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med (1996) 1.06

Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma. Br Med J (1980) 1.06

Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis (2000) 1.03

The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group. Eur J Cancer Care (Engl) (2013) 1.02

Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study. Eur Respir J (2011) 1.02

Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res (1997) 1.01

Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation. Int J Lepr Other Mycobact Dis (1980) 1.01

Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01

Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. Genomics (2001) 1.01

A potential hazard for night denture wearers. J Laryngol Otol (1994) 1.00

Doppler ultrasound probe for assessment of blood-flow in oesophageal varices. Lancet (1983) 0.99

Major constituents of the conidial wall of Neurospora crassa. Indian J Exp Biol (1970) 0.99

Comparison of allogeneic and xenogeneic determinants on the H-2Kk molecule. Transplantation (1983) 0.98

Role of enzymes in growth and morphology of Neurospora crassa: cell-wall-bound enzymes and their possible role in branching. J Bacteriol (1970) 0.98

Stress in the police service. J Occup Med (1982) 0.98

Trace element and Sigma DDT concentrations in horticultural soils from the Tasman, Waikato and Auckland regions of New Zealand. Sci Total Environ (2006) 0.97

Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid. Biochim Biophys Acta (1984) 0.97

Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand (2000) 0.96

Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med (1998) 0.96

Predicted maximal oxygen uptake in normal Hong Kong Chinese schoolchildren and those with respiratory diseases. Pediatr Pulmonol (2001) 0.96

A simple bioassay for detection of aflatoxin in milk. Toxicon (1969) 0.95

Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun (1991) 0.95

Systemic factors are trophic in bypassed rat small intestine in the absence of luminal contents. Gut (1990) 0.95

The morbidity from nasal splints in 105 patients. Clin Otolaryngol Allied Sci (1992) 0.94

Alterations in the membrane of macrophages from leprosy patients. Infect Immun (1983) 0.94

Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION). HIV Med (2011) 0.94

Biochemical alteration in cells following phagocytosis of M. leprae--the consequence--a basic concept. Int J Lepr Other Mycobact Dis (1980) 0.94

Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J Clin Pharmacol (1998) 0.93

Immunological features of HLA-B27 anterior uveitis. Aust J Ophthalmol (1983) 0.93

A new, low-volume protein substitute for teenagers and adults with phenylketonuria. J Inherit Metab Dis (2004) 0.93

Ultrasound and HIDA: scanning in evaluating bile leaks after cholecystectomy. Nucl Med Commun (1991) 0.92

The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax (2009) 0.92

Evaluation of Bioglass/dextran composite as a bone graft substitute. Int J Oral Maxillofac Surg (2002) 0.92

Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis. J Pathol (2007) 0.92

Bushfire impact on youth. J Trauma Stress (2010) 0.92

Hepatic elimination of flowing substrates: the distributed model. J Theor Biol (1978) 0.91

Characterization of an extracellular matrix-degrading protease derived from a highly metastatic tumor cell line. Eur J Cancer Clin Oncol (1985) 0.90

Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement. S Afr Med J (2014) 0.89

Jockey injuries in the United States. JAMA (2000) 0.88

Deactivation of visual transduction without guanosine triphosphate hydrolysis by G protein. Science (1992) 0.88

A mouse hepatocyte carbohydrate-specific receptor and its interaction with liver-metastasizing tumor cells. Int J Cancer (1983) 0.88

Effect of Valsalva's manoeuvre and hyoscinbutylbromide on the pressure gradient across the wall of oesophageal varices. Gut (1987) 0.88

Neuroradiological and neuropsychological assessment in anorexia nervosa. Psychol Med (1990) 0.87

High phenotypic correlations among siblings with autism and pervasive developmental disorders. Am J Med Genet (1996) 0.87

Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques. J Neurol Neurosurg Psychiatry (1998) 0.87